HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard Bianco Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stachelek, S. J. Articles by Levy, R. J. Search for Related Content PubMed PubMed Citation Articles by Stachelek, S. J. Articles by Levy, R. J. Related Collections Valve disease

Ann Thorac Surg 2006;81:47-55
© 2006 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Cholesterol-Modified Polyurethane Valve Cusps Demonstrate Blood Outgrowth Endothelial Cell Adhesion Post-Seeding In Vitro and In Vivo

^a Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
^b McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania
^c Department of Medicine, University of Minnesota School of Medicine, Minneapolis, Minnesota
^d Department of Surgery, University of Minnesota School of Medicine, Minneapolis, Minnesota

Accepted for publication July 18, 2005.

^_* Address correspondence to Dr Levy, The Children's Hospital of Philadelphia, 3615 Civic Center Blvd, Abramson Research Center, Suite 702, Philadelphia, PA 19104-4318 (Email: levyr{at}email.chop.edu).

BACKGROUND: The clinical and experimental use of polyurethane heart valve prostheses has been compromised by thrombosis and calcified thrombus. This is caused in part by the lack of an intact endothelium on these implant surfaces. We hypothesize that endothelial seeding of a polyurethane heart valve leaflet with autologous sheep blood outgrowth endothelial cells (BOECs) could be achieved with cholesterol-modified polyurethane (PU-Chol) to promote BOEC adhesion, thereby resulting in an intact, shear-resistant endothelium that would promote resistance to thrombosis.

METHODS: Cholesterol-derivatized polyurethane was formulated by bromoalkylation of the urethane nitrogens followed by reactive attachment of mercaptocholesterol. In vitro shear flow studies were carried out comparing BOEC retention on control surfaces versus PU-Chol using forces comparable to those observed in vivo with cardiac valves (75 dyne/cm²). Autologous sheep BOECs were seeded onto PU-Chol before pulmonary leaflet replacement surgery under cardiopulmonary bypass. Studies were terminated at 30 and 90 days followed by retrieval analyses.

RESULTS: Blood outgrowth endothelial cell seeding of PU-Chol surfaces resulted in an endothelial monolayer that was positive for von Willebrand factor. Polyurethane-cholesterol demonstrated significantly greater BOEC adhesion under 75 dyne/cm² shear force in vitro than control polyurethane (75.3% ± 12.3% versus 5.8% ± 3.9%, respectively; p < 0.001). Sheep pulmonary cusp replacements demonstrated retention of seeded BOECs on PU-Chol leaflets with no significant differences in the extent of cellular density comparing unimplanted specimens with explants. Control explants (nonseeded PU-Chol and nonseeded polyurethane) demonstrated no evidence of endothelial recruitment.

CONCLUSIONS: Polyurethane-cholesterol represents a polyurethane formulation with very high adhesive properties for BOECs under heart valve level shear forces both in vitro and in vivo.

This article has been cited by other articles:

				K. Schlaudraff Invited commentary Ann. Thorac. Surg., January 1, 2006; 81(1): 56 - 56. [Full Text] [PDF]